---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-219421"
form_type: "8-K"
ticker: "LCTX"
cik: "0000876343"
company_name: "Lineage Cell Therapeutics, Inc."
filed_at: "2026-05-12T20:10:17+00:00"
generated_at: "2026-05-12T21:07:54.133885+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lineage Q1 2026 net loss $4.8M; cash $53.4M; new COR1 program launched

## Summary
- Net loss $4.8M ($0.02 basic/$0.03 diluted EPS) vs $4.1M loss in Q1 2025.
- Revenue $1.7M (+$0.2M YoY) driven by new WDI collaboration.
- Cash & marketable securities $53.4M; expected to fund ops into Q2 2028.
- Launched COR1 corneal endothelial cell therapy; second OPC1 spinal cord patient dosed.
- First AlloSCOPE 5D milestone achieved; Joachim Fruebis appointed founding SAB member.

## SEC filing metadata
- accession: 0001193125-26-219421
- form_type: 8-K
- ticker: LCTX
- cik: 0000876343
- company_name: Lineage Cell Therapeutics, Inc.
- filed_at: 2026-05-12T20:10:17+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876343/000119312526219421/0001193125-26-219421-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876343/000119312526219421/lctx-20260512.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-219421
- JSON: https://secwatch.observer/filing/0001193125-26-219421.json
- Plain text: https://secwatch.observer/filing/0001193125-26-219421.txt

## Key facts
- Earnings Releases
  Lineage Cell Therapeutics, Inc. reported financial results for the quarter ended March 31, 2026.
  - Period: the quarter ended March 31, 2026
  - Result: reported results
  source text: On May 12, 2026, Lineage Cell Therapeutics, Inc. issued a press release announcing financial results for the quarter ended March 31, 2026
  evidence_url: https://www.sec.gov/Archives/edgar/data/876343/000119312526219421/0001193125-26-219421-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.